The main reasons are as follows: the immunosuppressive microenvironment is the most common cause of anti-PD-1 mAb resistance; previous studies have shown that neurotransmitters can mediate tumour progression by regulating the tumour immune microenvironment [23]. Here, PDCD1 is linked to neoplasm.